Sensor, Glucose, Invasive
MDS is the FDA product code for Sensor, Glucose, Invasive, a class III device type. FDA's definition for this code reads: "The device is a glucose-monitoring device indicated for detecting trends and tracking patterns in adults (age 18 and older) with diabetes. The device is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home glucose monitoring devices. The system aids in the...". As of , FDA records hold no 510(k) clearances under this code and 57 recalls.
Classification record
- Product code
- MDS
- Device name
- Sensor, Glucose, Invasive
- FDA definition
- The device is a glucose-monitoring device indicated for detecting trends and tracking patterns in adults (age 18 and older) with diabetes. The device is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home glucose monitoring devices. The system aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 57
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Medical
- Flextronics Industrial (Shenzhen) Co., Ltd.
- Intricon Corporation
- IntriCon Corporation Grey Fox
- IntriCon Corporation VH
- Medtronic Puerto Rico Operations Co., Juncos
- Medtronic, Inc.
- RR Donnelley-Supply Chain Solutions
- Sanmina Ireland UC
- Sterigenics Radiation Technologies in, Inc
- Synergy Health AST, LLC
- Synergy Health Ireland Ltd
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
